Tag Archives: biotech industry

Are GMOs the Climategate of the Left?

admin-ajax (2)

I’ve heard the word “momentum” a lot lately. Vermont signed its GMO labeling law on May 8. Voters in Jackson County, Oregon this week approved a ban on GMO cultivation, a move that will dictate to area farmers what they can and can’t grow. And just today, Senator Lisa Murkowski (R-AK) shepherded through the Appropriations Committee an amendment to mandate the labeling of the genetically engineered AquAdvantage salmon, when it is approved by the FDA. Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

San Francisco Business Times: Two JOBS Acts are better than one

scientist-eyedropper

Today, the San Francisco Business Times published an op-ed by OncoMed President and CEO Paul Hastings lauding the Jumpstart Our Business Startups Act (JOBS) Act for giving emerging biotech companies a much-needed boost. As Hastings points out, 80-plus companies will have gone public in the last two years with the help of the JOBS Act. As the biotech industry gathers in San Diego next month for the 2014 BIO International Convention, several CEOs in attendance will no Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Indiana Governor Signs Bill that Supports Transparent Communication

admin-ajax copy

Indiana Governor Mike Pence has signed bipartisan legislation enabling retail pharmacies within his state to substitute interchangeable biologic medicines, once approved, for the innovator drug on which they are based. Not only does this legislation empower pharmacists to use their professional discretion to automatically substitute interchangeable biologic medicines, it also ensures transparent communication within a patient’s entire health care team to ensure the best decisions possible. The newly signed Senate Bill 262 ensures pharmacists communicate with the Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

GM Crop Technology Provides Boost to Developing Country Farmers

Canola-115x76

Millions of farmers around the world continue to choose to plant and replant genetically modified (GM) crop varieties because of their environmental and socio-economic benefits and the important role they play in maintaining food security, according to a new study. The report, Global Status of Commercialized Biotech/GM Crops: 2013, released annually by the International Service for the Acquisition of Agri-Biotech Applications (ISAAA), says a record 18 million farmers in 27 countries are growing biotech crops on Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

#BIOCEO14: An Optimistic Outlook for 2014

Panel

The 16th Annual BIO CEO & Investor Conference​ concluded with a lively Closing Plenary Session examining the current capital market for IPOs, where the industry has been and where it’s headed in 2014. The panel unanimously agreed: 2013 was the year of the IPO. In total, 56 healthcare companies priced an IPO; 43 of these were biotech companies. Last year was the strongest IPO year since 2000 and the second strongest in history with over $10 Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,